Aripiprazole
Aripiprazole is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: Aripiprazole; Generic name: ARIPIPRAZOLE; Drug class: Atypical Antipsychotic [EPC].
| Brand name | Aripiprazole |
|---|---|
| Generic name | ARIPIPRAZOLE |
| Drug class | Atypical Antipsychotic [EPC] |
| Manufacturer | XLCare Pharmaceuticals, Inc. |
| Used for | 1 INDICATIONS AND USAGE Aripiprazole oral tablets are indicated for the treatment of: Schizophrenia Treatment of Tourette’s Disorder Aripiprazole tablets are an atypical antipsychotic. The oral formulations are indicated for: Schizophrenia (14.1) Treatment of Tourette’s disorder (14.5) |
| Dosage | 2 DOSAGE AND ADMINISTRATION Initial Dose Recommended Dose Maximum Dose Schizophrenia – adults (2.1) 10 to 15 mg/day 10 to 15 mg/day 30 mg/day Schizophrenia – adolescents (2.1) 2 mg/day 10 mg/day 30 mg/day Tourette’s disorder – (2.5) Patients < 50kg 2 mg/day 5 mg/day 10 mg/day Patients > 50kg 2 mg/day 10 mg/day 20 mg/day Oral formulations: Administer once daily without regard to meals (2) Known CYP2D6 poor metabolizers: Half of the usual dose (2.7) 2.1 Schizophrenia Adults The recommended startin |
| Warnings | WARNING: INCREASED MORTALITY IN ELDERLY PATIENTS WITH DEMENTIA-RELATED PSYCHOSIS and SUICIDAL THOUGHTS AND BEHAVIORS WITH ANTIDEPRESSANT DRUGS Elderly patients with dementia-related psychosis treated with antipsychotic drugs are at an increased risk of death. Aripiprazole tablets are not approved for the treatment of patients with dementia-related psychosis [see Warnings and Precautions (5.1)]. Antidepressants increased the risk of suicidal thoughts and behavior in children, adolescents, and you |
| Active ingredient(s) | ARIPIPRAZOLE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=0a6fa113-6bb2-4f88-af07-ce0914c98ff2 |